MedWatch

Analyst believes in continued progress for Ambu

When Ambu reveals its Q2 financial report on Wednesday morning, Sydbank analyst Søren Løntoft Hansen expects to see continued strong growth for single-use endoscopes.

Photo: Sydbank/PR

Ambu has had wind in its sails when it comes to the sale of single-use endoscopes, which may very well continue into the second quarter of the financial year 2020/2021.

However, the growth for the company's visualization business leg is hard to compare to the second quarter last year, Søren Løntoft Hansen, senior equity analyst at Sydbank warns.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs